Back
Cocrystal Pharma Vs. Perspective Therapeutics Industry Stock Comparison
Buy
60
COCP
Cocrystal Pharma
Last Price:
1.79
Seasonality Move:
15.92%
Sell
30
CATX
Perspective Therapeutics
Last Price:
10.61
Seasonality Move:
28.97%
Buy
60
Cocrystal Pharma (COCP)
is a Buy
Is Cocrystal Pharma a Buy, Sell or Hold?
- The current Cocrystal Pharma [COCP] share price is $1.78. The Score for COCP is 60, which is 20% above its historic median score of 50, and infers lower risk than normal.
- COCP is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
30
Perspective Therapeutics (CATX)
is a Sell
Is Perspective Therapeutics a Buy, Sell or Hold?
- The current Perspective Therapeutics [CATX] share price is $11.09. The Score for CATX is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
- CATX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
COCP Stock Price Chart
What is Cocrystal Pharma's stock price today?
-
The Cocrystal Pharma share price today is $1.78
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and COCP is experiencing slight buying pressure.
CATX Stock Price Chart
What is Perspective Therapeutics's stock price today?
-
The Perspective Therapeutics share price today is $11.09
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATX is experiencing selling pressure, which indicates risk of future bearish movement.
COCP Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.02 | Sell |
| Relative Strength Index (14 RSI): | 47.06 | Sell |
| Chaikin Money Flow: | 2494 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.72 - 1.98) | Sell |
| Bollinger Bands (100): | (1.68 - 2.22) | Sell |
CATX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.39 | Sell |
| Relative Strength Index (14 RSI): | 36.31 | Sell |
| Chaikin Money Flow: | -440241 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (11.64 - 12.86) | Sell |
| Bollinger Bands (100): | (11.26 - 14.34) | Sell |
COCP Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 1.77 | Buy |
| 20-day SMA: | 1.87 | Sell |
| 50-day SMA: | 1.79 | Sell |
| 200-day SMA: | 1.84 | Sell |
| 8-day EMA: | 1.78 | Sell |
| 20-day EMA: | 1.82 | Sell |
| 50-day EMA: | 1.84 | Sell |
| 200-day EMA: | 1.92 | Sell |
CATX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.86 | Sell |
| 20-day SMA: | 12.04 | Sell |
| 50-day SMA: | 13.07 | Sell |
| 200-day SMA: | 12.76 | Sell |
| 8-day EMA: | 11.7 | Sell |
| 20-day EMA: | 12.06 | Sell |
| 50-day EMA: | 12.64 | Sell |
| 200-day EMA: | 11.76 | Sell |
Cocrystal Pharma Earnings Growth & COCP Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.15 per share, and a decrease next year of $0.27 per share.
Perspective Therapeutics Earnings Growth & CATX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.11 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.17 per share.
Cocrystal Pharma Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Perspective Therapeutics Technical Analysis
| Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct | Nov | |||||||||
| 29 | 30 | 31 | 01 | 04 | 05 | 06 | 07 | 08 | 11 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||